Full Press Release Details
Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering
Florida, Feb. 21, 2025 (GLOBE NEWSWIRE) - Wellgistics Health, Inc. (the "Company"), a holding company for various
existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced the pricing
of its initial public offering (the "Offering") of 888,889 ordinary shares at a public offering price of $4.50 per ordinary
share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on February
21, 2025, under the ticker symbol "WGRX."
Company expects to receive aggregate gross proceeds of $4.0 million from the Offering, before deducting underwriting discounts and other
related expenses. The Offering is expected to close on or about February 24, 2025, subject to the satisfaction of customary closing conditions.
With the Offering, the Company expects to increase capitalization, financial flexibility, increase visibility in the marketplace, and
create a public market for Common Stock. The net proceeds from the Offering will be primarily used for general corporate purposes, including
working capital, marketing initiatives, and capital expenditures.
Offering is being conducted on a firm commitment basis. Craft Capital Management LLC and D. Boral Capital LLC acted as underwriters for
the Offering (the "Underwriters"). Dykema Gossett PLLC is acting as securities counsel to the Company, and Sichenzia Ross
Ferrance Carmel LLP is acting as securities counsel to the Underwriters in connection with the Offering.
registration statement on Form S-1 relating to the Offering was filed with the U.S. Securities and Exchange Commission (the "SEC")
(File Number: 333-280925) and was declared effective by the SEC on February 14, 2025. The Offering is being made only by means of a prospectus,
forming a part of the registration statement. Copies of the prospectus relating to the Offering may be obtained, when available, from
Craft Capital Management LLC by standard mail to Craft Capital Management LLC, 377 Oak St, Lower Concourse, Garden City, NY 11530 or
by email at info@craftcm.com, or by telephone at +1(516)-833-1325; or from D. Boral Capital LLC by standard mail to D. Boral Capital
LLC, 590 Madison Ave 39th Floor, New York, NY 10022, or by email at info@dboralcapital.com, or by telephone at +1(212)-970-5150.
In addition, copies of the prospectus relating to the Offering may be obtained via the SEC's website at www.sec.gov.
you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about
the Company and the Offering. This press release has been prepared for informational purposes only and shall not constitute an offer
to sell, or the solicitation of an offer to buy any of the Company's securities, nor shall there be any offer, solicitation or
sale of any of the Company's securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of such state or jurisdiction.
Wellgistics Health, Inc.
Health is a holding company for existing and future planned operating companies centered around healthcare technology and pharmaceutical
services. It seeks to be a micro health ecosystem, with a portfolio of companies consisting of a technology platform, pharmacy, and wholesale
operations that provide novel prescription hub and clinical services. Wellgistics Health is focused on improving the lives of patients
while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. With the successful integration
of its patient-centric approach and innovative healthcare applications, Wellgistics Health intends to shift the dynamic of pharmaceutical
care to revolve around the patient for a wide range of therapeutic conditions by offering a full spectrum of integrated solutions as
a result of leveraging the synergies of its business segments to address access, care coordination, dispensing, delivery, and clinical
management of pharmaceutical products ranging from "specialty-lite" to general maintenance conditions. For more information,
please visit the Company's website: https://wellgisticshealth.com/
press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals,
strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical
facts. When the Company uses words such as "may, "will, "intend," "should," "believe,"
"expect," "anticipate," "project," "estimate" or similar expressions that do not relate
solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation,
the Company's statements regarding the expected trading of its Ordinary Shares on the Nasdaq Capital Market and the closing of
the Offering. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause
the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements
are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion
of the initial public offering on the anticipated terms or at all, and other factors discussed in the "Risk Factors" section
of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance
upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC,
which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements
to reflect events or circumstances that arise after the date hereof.
more information, please contact: